1. Scrip
  2. >>Business

GSK Management Shake Up Ahead Of New CEO Sees Hussain Out, AZ's Miels In

 
• By Sukaina Virji

"Succession processes are challenging for everyone involved and, unfortunately, it is rare that all of those involved stay with the company," stated GSK's out-going CEO Andrew Witty, as Abbas Hussain decides to leave the company having lost out on the top job, which went to Emma Walmsley. His successor will be AstraZeneca's Luke Miels.

Resignation

GlaxoSmithKline PLC's Abbas Hussain, president of its global pharmaceuticals unit, will leave the company later this year. He will be replaced by Luke Miels, currently head of AstraZeneca PLC's European business.

The news follows the appointment of Emma Walmsley as Andrew Witty's successor

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip